Navigation Links
High risk of acute mountain sickness on Mount Kilimanjaro

New Rochelle, NY, October 6, 2010 Climbers of high peaks such as Mount Kilimanjaro are at high risk for Acute Mountain Sickness (AMS). Trekkers should not ignore AMS warning signs, which can progress to more serious medical outcomes. Mountain climbers can best minimize their risk for altitude sickness by becoming acclimatized to increased altitudes before an ascent, according to a study in the current issue of High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. ( The article is available free online at

The study, entitled "Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro," evaluated the incidence of AMS among trekkers of this popular climbing destination. Stewart Jackson, J. Kenneth Baillie, and colleagues from University of Edinburgh (Scotland) and Muhimbili University College of Health Science (Tanzania), compared the effects of three increasingly difficult and rapid ascent routes, the option of a single rest day during the climb, and use by a sub-group of climbers of prophylactic acetazolamide.

The authors reported a similar rate of AMS among climbers with or without prophylactic drug use. Furthermore, a mid-climb rest day did not affect the incidence of AMS. Only prior acclimatization to increased altitude offered a significant protective effect against AMS.

"This important article emphasizes the dangers of rapid ascent rates on a mountain that attracts thousands of visitors every year. Hopefully it will help to reduce the high frequency of high altitude diseases," says John B. West, MD, PhD, Editor-in-Chief of High Altitude Medicine & Biology and Professor of Medicine at the University of California, San Diego School of Medicine.


Contact: Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News

Page: 1

Related biology news :

1. Vitamin C rapidly improves emotional state of acutely hospitalized patients, say LDI researchers
2. CoLucid Pharmaceuticals, Inc. announces study data documenting oral efficacy of lasmiditan (COL-144), a selective 5-HT1F receptor agonist, in the treatment of acute migraine attacks
3. Drinking alcohol during pregnancy could lead to acute myeloid leukemia in children
4. Vicious circle offers new acute leukemia treatment target
5. Study shows pine bark naturally relieves symptoms of acute hemorrhoids
6. First-in-class treatment for acute leukemia
7. Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia
8. Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients
9. A miR boost enables acute leukemia cells to mature
10. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
11. When acute hepatitis develops into chronic hepatitis
Post Your Comments:
Related Image:
High risk of acute mountain sickness on Mount Kilimanjaro
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
(Date:10/29/2015)... , October 29, 2015 ... biometric authentication company focused on the growing mobile ... wallet announces that StackCommerce, a leading marketplace to ... featuring the Wocket® smart wallet on StackSocial for ... ) ("NXT-ID" or the "Company"), a biometric authentication ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... 24, 2015 Capricor Therapeutics, Inc. ... the discovery, development and commercialization of first-in-class therapeutics, today ... Officer, is scheduled to present at the 2015 Piper ... a.m. EST, at The Lotte New York Palace Hotel ... . --> . ...
(Date:11/24/2015)... INCLINE VILLAGE, Nev. , Nov. 24, 2015  PDL ... John P. McLaughlin , the company,s president and chief ... Piper Jaffray Healthcare Conference next week in New ... and will occur on Tuesday, December 1, 2015 at 9:30 ... and Presentations." Please connect to the website at least 15 ...
(Date:11/24/2015)... ... , ... Whitehouse Laboratories is pleased to announce that it has completed construction ... dedicated to basic USP 61, USP 62 and USP 51 testing specific to raw ... and micro testing performed by one supplier. Management has formally announced that ...
(Date:11/23/2015)... , Nov. 24, 2015 Women with a certain ... exams face a higher risk of lung cancer than men ... next week at the annual meeting of the Radiological Society ... --> --> Lung nodules are ... as solid or subsolid based on their appearance on CT. ...
Breaking Biology Technology: